Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane.
Agarwal
Manisha
M
Chaudhary
S P
SP
Narula
Ritesh
R
Rajpal
Simpy
S
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000150:complications*; D003131:Combined Modality Therapy; D006801:Humans; D056965:Injections, Intraocular; D008297:Male; D008875:Middle Aged; D011312:Pressure; D012166:Retinal Hemorrhage / Q000150:complications / Q000628:therapy*; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab